HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

Preventing Heart Attacks

Researchers studied all people with type 2 diabetes hospitalized for a first heart attack within a five-county area around Philadelphia during a 56-month period. For comparison purposes, a randomly selected group of people with diabetes in the community was evaluated as well. Patients who were on monotherapy with thiazolidinedione had one-third the risk, and those on monotherapy with metformin were nearly half as likely to suffer a heart attack as those on sulfonylurea alone. Adding thiazolidinedione to sulfonylurea significantly reduced heart attack risk, while metformin did not.

Further research may help shed light on potential differences in insulin-sensitizing drugs, the authors conclude.

Sauer WH, Cappola AR, Berlin JA, et al.: Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 87: 651–654, 2006 .

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?